Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07219108 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

Study acronym: TAVERN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 10 entries
    • Eligibility criteria expanded, about 28 words
    • Secondary endpoints: details revised at 7 of 9 entries
    • Publications: details revised at 3 of 3 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.
Trial Details
NCT Number NCT07219108
Lead Sponsor Washington University School of Medicine
Conditions
(from sponsor)		 Acute Neurological Injury, Acute Medical Conditions
Related terms Brain Diseases, Central Nervous System Diseases, Hemorrhage, Pathologic Processes, Vascular Diseases
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov